European Growth Companies With High Insider Ownership For November 2025

As European markets navigate the relief of the U.S. federal government reopening, tempered by cooling sentiment around artificial intelligence, investors are keenly observing growth stocks with high insider ownership as potential opportunities. In such a climate, companies where insiders hold significant stakes may offer added confidence to investors due to their vested interest in long-term success and resilience amidst fluctuating economic conditions.

Top 10 Growth Companies With High Insider Ownership In Europe

Name	Insider Ownership	Earnings Growth
Pharma Mar (BME:PHM)	12%	42.6%
MilDef Group (OM:MILDEF)	13.7%	83%
MedinCell (ENXTPA:MEDCL)	12.5%	96.3%
KebNi (OM:KEBNI B)	36.3%	61.2%
Egetis Therapeutics (OM:EGTX)	10.3%	86.1%
DNO (OB:DNO)	13.5%	97.5%
CTT Systems (OM:CTT)	17.5%	52%
Circus (XTRA:CA1)	24.1%	65.5%
CD Projekt (WSE:CDR)	29.7%	51%
Bonesupport Holding (OM:BONEX)	10.4%	49.7%

Click here to see the full list of 202 stocks from our Fast Growing European Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Moltiply Group (BIT:MOL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Moltiply Group S.p.A. is a holding company engaged in the financial services industry with a market capitalization of €1.56 billion.

Operations: Moltiply Group S.p.A. generates its revenue through various segments within the financial services sector.

Insider Ownership: 23.4%

Moltiply Group's revenue is forecast to grow at 11.1% annually, outpacing the Italian market's 5.4%. Earnings are expected to rise significantly at 28% per year, surpassing market averages. Recent earnings reports showed strong growth, with Q3 sales reaching €171.19 million and net income of €16.69 million. While insider buying has occurred recently, it hasn't been substantial in volume. Analysts agree on a potential stock price increase of 43.3%.

• Get an in-depth perspective on Moltiply Group's performance by reading our analyst estimates report here.
• Our comprehensive valuation report raises the possibility that Moltiply Group is priced higher than what may be justified by its financials.

Paratus Energy Services (OB:PLSV)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Paratus Energy Services Ltd. offers drilling services through its subsidiaries and manages a fleet of jack-up rigs under contracts in Mexico, with a market cap of NOK6.70 billion.

Operations: The company's revenue segments include Fontis, contributing $176 million, and Seagems, generating $209.20 million.

Insider Ownership: 30.3%

Paratus Energy Services is trading significantly below its estimated fair value, with analysts predicting a 31.9% price rise. The company is expected to become profitable in three years, surpassing average market growth. Although revenue growth is modest at 3.8% annually, it exceeds the Norwegian market's pace. Recent financial maneuvers include purchasing $17.6 million in notes funded by proceeds from an Archer Limited share sale, reducing outstanding debt and potentially enhancing financial stability amidst declining earnings performance compared to last year.

• Click here and access our complete growth analysis report to understand the dynamics of Paratus Energy Services.
• Our valuation report unveils the possibility Paratus Energy Services' shares may be trading at a discount.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €1.27 billion.

Operations: Redcare Pharmacy NV generates revenue through its DACH segment, accounting for €2.30 billion, and its International segment, contributing €519 million.

Insider Ownership: 13.5%

Redcare Pharmacy is trading significantly below its estimated fair value, with revenue growth forecasted at 15.5% annually, outpacing the German market. The company anticipates becoming profitable within three years, reflecting strong growth potential. Recent executive changes include appointing Hendrik Krampe as CFO, bringing substantial experience from Amazon and eBay to bolster strategic initiatives. Despite a net loss reduction to €8.71 million for the first nine months of 2025, sales surged to €2.15 billion from €1.70 billion year-over-year.

• Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report.
• Our valuation report here indicates Redcare Pharmacy may be overvalued.

Make It Happen

• Navigate through the entire inventory of 202 Fast Growing European Companies With High Insider Ownership here.
• Want To Explore Some Alternatives? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com